Science and Innovation
The US Pharmaceutical Industry during the 1980s
Seiten
1995
Cambridge University Press (Verlag)
978-0-521-45118-5 (ISBN)
Cambridge University Press (Verlag)
978-0-521-45118-5 (ISBN)
This text deals with an important phenomenon for competitiveness and innovation in industry - the growing use of basic scientific principles in industrial research. It focuses on the pharmaceutical industry, and discusses how developments in molecular biology are influencing the strategies of drug companies.
This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D.
This book examines an important phenomenon for competitiveness and innovation in industry: namely the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies and competition. Science and Innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences since the 1980s have exerted on the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labour between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery and the productivity of R & D.
List of figures; List of tables; Preface; List of abbreviations; 1. Introduction; 2. Science and innovation in pharmaceutical research; 3. Economic implications of greater scientific intensity in drug research; 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies; 5. Scientific research and drug discovery: an econometric investigation; 6. A model of the innovation cycle in the pharmaceutical industry; 7. Complementarity and external linkages: the strategies of large firms in biotechnology; 8. Conclusions; Notes; References; Index.
| Erscheint lt. Verlag | 9.3.1995 |
|---|---|
| Zusatzinfo | 26 Tables, unspecified; 6 Line drawings, unspecified |
| Verlagsort | Cambridge |
| Sprache | englisch |
| Maße | 158 x 236 mm |
| Gewicht | 466 g |
| Themenwelt | Geschichte ► Teilgebiete der Geschichte ► Wirtschaftsgeschichte |
| Medizin / Pharmazie ► Pharmazie | |
| Technik | |
| ISBN-10 | 0-521-45118-3 / 0521451183 |
| ISBN-13 | 978-0-521-45118-5 / 9780521451185 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
